efgartigimod alfa, Antibody of Fc fragment of IgG receptor and transporter, Antibody of Fc fragment of IgG receptor and transporter

Features and benefits
    In stock
    Item Number
    Ab175520
    Grouped product items
    SKUSizeAvailabilityPrice Qty
    Ab175520-1mg
    1mg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $2,668.90
    Ab175520-5mg
    5mg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $4,668.90

    Basic Description

    Product Nameefgartigimod alfa, Antibody of Fc fragment of IgG receptor and transporter
    Specifications & PurityMoligand™
    GradeMoligand™
    Action TypeANTAGONIST
    Mechanism of actionAntibody of Fc fragment of IgG receptor and transporter

    Product Properties

    CASAb175520

    Associated Targets(Human)

    FCGRT Tclin IgG receptor FcRn large subunit p51 (0 Activities)
    Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Certificates(CoA,COO,BSE/TSE and Analysis Chart)

    C of A & Other Certificates(BSE/TSE, COO):
    Analytical Chart:

    Specifications

    References

    1. Liu L, Garcia AM, Santoro H, Zhang Y, McDonnell K, Dumont J, Bitonti A.  (2007)  Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade..  J Immunol,  178  (8): (5390-8).  [PMID:17404325] [10.1021/op500134e]
    2. Petkova SB, Akilesh S, Sproule TJ, Christianson GJ, Al Khabbaz H, Brown AC, Presta LG, Meng YG, Roopenian DC.  (2006)  Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease..  Int Immunol,  18  (12): (1759-69).  [PMID:17077181] [10.1021/op500134e]
    3. Vaccaro C, Zhou J, Ober RJ, Ward ES.  (2005)  Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels..  Nat Biotechnol,  23  (10): (1283-8).  [PMID:16186811] [http://pubmed.ncbi.nlm.nih.gov/16186811]
    4. Roopenian DC, Akilesh S.  (2007)  FcRn: the neonatal Fc receptor comes of age..  Nat Rev Immunol,  (9): (715-25).  [PMID:17703228] [10.1021/op500134e]

    Solution Calculators

    Reviews

    Customer Reviews